Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Clinical trial NCT02390752 · RECRUITING

Trial details

NCT number

NCT02390752

Sponsor

National Cancer Institute (NCI)

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2015-04-29

Primary completion

2026-12-31

Enrollment

54

View on ClinicalTrials.gov